Abstract
IL-17 is involved in the recruitment of eosinophils and neutrophils. Despite its inhibition being able to modulate inflammatory and functional responses in asthma and COPD, there are no studies addressing these aspects in ACO. Currently, treatments with monoclonal antibodies are important for patients with difficult-to-control asthma. Therefore, the study of IL-17 in patients with ACO bec…